These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6171343)

  • 21. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
    Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
    Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of fluoropyrimidine cytotoxicity in l1210 cells: correlation with inhibition of thymidylate synthetase but not with incorporation into RNA.
    Danenberg KD; Becker D; Mulkins MA; Danenberg PV
    Pharm Res; 1984 May; 1(3):110-5. PubMed ID: 24277246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
    Cory JG; Breland JC; Carter GL
    Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH; el Kouni MM; Naguib FN
    Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
    Ardalan B; Cooney DA; Jayaram HN; Carrico CK; Glazer RI; Macdonald J; Schein PS
    Cancer Res; 1980 May; 40(5):1431-7. PubMed ID: 6245793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
    Roobol C; De Dobbeleer GB; Bernheim JL
    Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
    Parker WB; Klubes P
    Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil.
    Washtien WL
    Mol Pharmacol; 1984 Jan; 25(1):171-7. PubMed ID: 6708932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of administration route in the therapeutic efficacy of doxifluridine.
    Trave F; Canobbio L; Au JL; Rustum YM
    J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
    Keniry M; Benz C; Shafer RH; James TL
    Cancer Res; 1986 Apr; 46(4 Pt 1):1754-8. PubMed ID: 3456267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.